Lightnews — Scholar-powered news

Medicines Patent Pool @medicinespatentpool.org · 3d

MPP and the Vizuri Health Dynamics Foundation are partnering to strengthen #local pharmaceutical #manufacturing and improve access to essential medicines in LMICs.

👉 medicinespatentpool.org/story-post/m...

Reposted by Medicines Patent Pool

Drugs for Neglected Diseases initiative (DNDi) @dndi.org · 6d

Children are too often left out of clinical trials. In Nature, our Head of HIV Justine Odionyi calls for drug development on neglected diseases to include children from the start. Read the piece (EN/FR): @nature.com #BeatNTDs #GlobalHealth www.nature.com/articles/d44...

Drug development for neglected diseases must account for kids

Including children in trials, shaping regulation locally, could deliver safer, more effective therapies in Africa.

www.nature.com

4 5

Medicines Patent Pool @medicinespatentpool.org · 5d

@accesstomedicinefoundation.org

Medicines Patent Pool @medicinespatentpool.org · 5d

At the UN High-Level Meeting on NCDs and Mental Health, MPP and partners convened a roundtable on expanding access to NCD medicines in LMICs.

Together, we aim to turn commitments into action for equitable, affordable access. 🌍

medicinespatentpool.org/news-publica...

1

Medicines Patent Pool @medicinespatentpool.org · 7d

Voluntary #LicensingSavesLives by making medicines and health technologies affordable for low- and middle-income countries. 🌍

🤝 But we cannot achieve this great change without your help!

👉 medicinespatentpool.org/licensingsav...

1 1

Medicines Patent Pool @medicinespatentpool.org · 16d

Last week, our India and Geneva teams came together for the annual all-staff retreat, a great moment to reflect and plan ahead.☀️ We explored MPP’s future strategy, priorities and ongoing #LicensingSavesLives campaign.

Thank you to all colleagues for your energy, we look forward to what lies ahead!

2

Medicines Patent Pool @medicinespatentpool.org · 16d

Around 375 patients with #chronicmyeloidleukaemia (CML) in El Salvador, Indonesia & the Philippines are now accessing quality-assured generic #nilotinib.

Made possible through a #voluntarylicence from @novartis.bsky.social to MPP via the ATOM coalition - @uiccofficial.bsky.social!

lnkd.in/eruiP-Gv

Medicines Patent Pool @medicinespatentpool.org · 16d

🌍 MPP joined the Joint @who.int @unaids.org @unitaid.bsky.social annual consultation!

Judith Federhofer shared updates on long-acting HIV treatment and the CAB-LA licence amendment for treatment + PrEP. @eburrone.bsky.social discussed access and pricing for #long-acting prevention in LMICs.

2 4

Medicines Patent Pool @medicinespatentpool.org · 21d

We’re proud to be recognized in the 2025 Global Health 50/50 Report as a high performer!

MPP’s new Menstrual & Menopause Policy supports women’s health needs through flexible work, awareness & training.

Read more: global5050.org/2025-report/

1 1

Medicines Patent Pool @medicinespatentpool.org · Sep 5

MPP welcomes the updated @who.int Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc).

We remain committed to enabling #access to essential medicines through #voluntarylicensing, #technologytransfer, and #manufacturing support.

👉 lnkd.in/dmr98RHf

Medicines Patent Pool @medicinespatentpool.org · Aug 25

📢 MPP is looking for a new Expert Advisory Group (EAG) Member!

🗓️ Deadline to apply: 31 August 2025
📩 Apply by sending your CV and cover letter to [email protected]

More info 👉 medicinespatentpool.org/who-we-are/c...

#Vaccines #AccessToMedicines #PublicHealth #JobOpportunities

Medicines Patent Pool @medicinespatentpool.org · Aug 21

🌍 Join our mission

📢 Request for Proposals – Feasibility and Concept Design Expert – GMP mRNA Vaccine Manufacturing in Africa 
📢 Request for Proposals – GLP1-RA Market Assessment for Obesity Treatment. 
📢 Board Member Opportunity

👉 medicinespatentpool.org/who-we-are/c...

1

Medicines Patent Pool @medicinespatentpool.org · Aug 20

Taking HIV pills daily can be overwhelming. 💉 Long-acting injectables offer hope, safe and effective. LMICs still lack timely access. #Voluntarylicensing can change that, ensuring the most vulnerable benefit from innovation.

📖 www.sciencedirect.com/science/arti...

👉 www.youtube.com/watch?v=GGDM...

Expanding access to long-acting HIV therapy in low-income and middle-income countries

YouTube video by MedicinesPatentPool

www.youtube.com

1

Medicines Patent Pool @medicinespatentpool.org · Aug 15

📢 Request for Proposal – GLP1-RA Market Assessment for Obesity Treatment

🗓 Deadline for submission: 7 September 2025
👉 To apply, send your proposal to [email protected]

Full details here: medicinespatentpool.org/who-we-are/c...

Medicines Patent Pool @medicinespatentpool.org · Aug 13

🌟 Welcoming our new Expert Advisory Group members!

We are delighted to welcome four new members to the @medicinespatentpool.org’s EAG.

🙏 A thank you to all our EAG members for their continued support and expertise in advancing MPP’s mission to increase #access to life-saving medicines 🌏.

Reposted by Medicines Patent Pool

Medicines Patent Pool @medicinespatentpool.org · Jul 25

🚨 We’re hiring!
⚖️ Associate Counsel
💉 Consultant: Feasibility & Concept Design Expert

👉 Check out our career page for more information: medicinespatentpool.org/who-we-are/c...

#GlobalHealth #AccessToMedicines #mRNA #Vaccines #Hiring

3 2

Medicines Patent Pool @medicinespatentpool.org · Jul 28

🌍 #WorldHepatitisDay2025

Charles Gore, founder of World Hepatitis Day, @worldhepalliance.bsky.social and MPP’s Executive Director, reminds us: 1.3M people die each year from viral hepatitis, and these deaths are preventable.

🔗 Full message: medicinespatentpool.org/news-publica...

2 2

Medicines Patent Pool @medicinespatentpool.org · Jul 25

🚨 We’re hiring!
⚖️ Associate Counsel
💉 Consultant: Feasibility & Concept Design Expert

👉 Check out our career page for more information: medicinespatentpool.org/who-we-are/c...

#GlobalHealth #AccessToMedicines #mRNA #Vaccines #Hiring

3 2

Medicines Patent Pool @medicinespatentpool.org · Jul 23

“We don’t have to explain ourselves all over again.”

In Kigali, we visited HDI, led by Dr. Aflodis Kagaba, where sex workers, LGBTQ+ people & people who use drugs find stigma-free care, every day.

✍️ Read the full story: medicinespatentpool.org/story-post/b...

1 3

Medicines Patent Pool @medicinespatentpool.org · Jul 23

Mila Maistat, Senior Manager at MPP, took part in the ASEAN dialogue on access to ARVs 🌏

🤝 She joined discussions with governments, health professionals, and communities to review progress in ARV access through MPP licences and the transition to WHO-recommended first-line treatments.

2

Medicines Patent Pool @medicinespatentpool.org · Jul 22

🔬 MPP's prioritisation framework guides our focus towards interventions where voluntary licensing can have the greatest public health impact.

📘 Our 2024 annual report: medicinespatentpool.org/news-publica...

👉 Our prioritisation page: medicinespatentpool.org/progress-ach...

1

Reposted by Medicines Patent Pool

WHO @who.int · Jul 15

Too many children are given medicines that were never properly tested for them.

That means imprecise dosing—and real risks.

💡 The Global Accelerator for Paediatric Formulations Network (GAP-f) is changing the game.

🔗 bit.ly/4lkpLZk

Illustration of a small child standing next to a big ladder. Text reads 'Why are children put at risk with medicines that are not designed for their age?'. Below it, text reads '38-50% of medicines used for children are prescribed off-label.'

2 31 110

Reposted by Medicines Patent Pool

Unitaid @unitaid.bsky.social · Jul 16

Unitaid applauds ViiV Healthcare and the @medicinespatentpool.org for advancing equitable access to HIV treatment. Strong partnerships like this help deliver life-changing innovations to the communities that need them most.

Learn more: medicinespatentpool.org/news-publica...

4 5

Reposted by Medicines Patent Pool

WHO @who.int · Jul 14

Many essential medicines are not designed for children.

That means crushed pills, inaccurate doses, and bitter tastes that make treatment hard to take.

The Global Accelerator for Paediatric Formulations Network (GAP-f) is working to close this gap.

🔗 bit.ly/4lkpLZk

#HealthForAll

Text reads 'Why are children still waiting for medicines adults have had for years?' near the illustration of a child looking sad with balloons flying away. Text below reads 'Only 30% of essential medicines are available in child-appropriate formulations.'

2 34 160

Medicines Patent Pool @medicinespatentpool.org · Jul 15

Expanding the #voluntarylicence for cabotegravir long-acting from #HIV prevention to treatment builds on 10+ years of #MPP–#ViiVHealthcare collaboration.
Founded by #Unitaid in 2010, MPP helped 23M+ access DTG—now doing the same for CAB LA with generic partners for prevention and treatment.

1 3